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Background: Studies show that patients are significantly less satisfied with torso scars than scars else-
where. Though not an uncommon practice, it is unknown if application of adhesive tapes following 
dermatological surgery help improve cosmesis.
Objective: To determine the effect of taping sutured torso wounds on overall scar appearance, scar 
width and patient satisfaction with the scar.
Patients/Methods: Participants having elliptical torso skin excisions in a primary care setting in re-
gional Australia were randomized in a single-blinded, controlled trial to 12 weeks taping (interven-
tion) or usual care (control) following deep and subcuticular suturing. A blinded assessor reviewed 
scars at three and six months.
Results: Of 195 participants recruited, 136 (63 taped, 73 controls) completed six months of follow-up. 
Independent blinded assessment of overall scar appearance was significantly better in taped partici-
pants (p= 0.004). Taping reduced median scar width by 1 mm (p=0.02) and when stratified by gender, 
by 3.0 mm in males (p=0.04) and 1.0 mm in females (p=0.2). High participant scar satisfaction was 
not further improved by taping.
Conclusion: Taping elliptical torso wounds for 12 weeks after dermatologic surgery improved scar 
appearance at six months.
ABSTRACT
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researcher trained staff to ensure consistency of data collec-
tion and standardization of management.
The study nurse phoned participants within five days of 
surgery and then fortnightly for 12 weeks to ascertain anal-
gesia requirements, wound complications and intervention 
compliance. Wound assessment was encouraged at three and 
six months even if participants had not been fully compliant 
with the intervention protocol.
Every participant gave signed informed consent and 
received written postoperative wound care information.
Eligibility criteria
Patients aged 18 to 80 years requiring elliptical skin excisions 
on the torso were eligible for the study provided they could 
easily reach the wound or had someone available to help 
with taping. Exclusion criteria included known tendency to 
keloid scarring; allergy to the sutures or skin tapes; flap sur-
gery; and prescribed immunosuppressive drugs. Participants 
requiring a second wider excision for residual tumor or mel-
anoma were subsequently excluded from the study.
Surgical wound management protocol
We used a standardized surgical procedure (Figure 1). In 
addition to deep and subcuticular sutures, an occasional 
superficial interrupted 3/0 nylon suture was used where nec-
essary to improve wound edge apposition.
Melolin dressings (Smith and Nephew Medical Ltd, 
Hull, UK), applied immediately after surgery, were changed 
after seven days (or sooner if soiled) and removed along 
with sutures 14 days postoperatively. A splash-proof dress-
ing cover (Opsite Flexifix, Smith and Nephew Medical Ltd, 
Hull, UK) was used, making showering easier for partici-
pants. In the hotter more humid months (November to Feb-
ruary inclusive), however, we used non-waterproof dressing 
covers (Fixomul Stretch, BSN Medical, Hamburg, Germany), 
allowing wounds to breathe better.
Intervention
Adhesive tapes 100 mm long and 10 mm wide (Leukostrips, 
Smith and Nephew Medical Ltd, Hull, UK) were applied per-
pendicularly to the sutured wound, in parallel without over-
lapping, prior to the dressing (Figure 2). It has been shown 
that tapes adhere to skin for longer with this technique 
[15]. Participants and carers were shown how to apply and 
remove tapes as well as receiving written instructions and a 
descriptive photo of the taping technique (Figure 3).
Instructions were given to change tapes on the same day 
each week for 12 consecutive weeks and to trim tape ends 
if they lifted. If no more than 4 cm extending either side of 
the scar, instructions were given to replace this tape and still 
change all tapes on the scheduled weekday.
Introduction
Dermal postoperative repair produces scar tissue that can 
cause significant psychological and physical consequences 
[1,2]. With an estimated 55 million elective operations 
occurring each year in the developed world alone [3] and 
confirmation that most patients (irrespective of age, gender 
and ethnicity) believe that even a small improvement in scar-
ring is worthwhile [4], any research that may help improve 
scar outcome is meaningful.
Research has confirmed a positive correlation between 
tension and increased scar tissue formation [5,6]. The great 
range of movement afforded by the spine renders scars on the 
trunk particularly vulnerable to tension and subsequent dis-
figurement. It may therefore not be surprising that patients 
are significantly more dissatisfied with torso scars than other 
scars [7-9]. Dermatologic surgery on the trunk is common 
worldwide, and in Australia 27% of all basal cell carcinomas 
(BCCs), 8% of all squamous cell carcinomas (SCCs), 25% of 
all invasive melanoma in men and 11% of all invasive mela-
noma in women are excised from the torso [10,11].
Evidence shows that prolonged use of adhesive tapes 
applied along a scar following surgery may reduce scar vol-
ume and improve cosmetic outcome [12,13]. Though short-
term taping following dermatological surgery may be stan-
dard protocol for many practices, the optimal duration and 
mechanism of action of this intervention remains unclear 
[12,14].
The aim of this study was to determine the impact of 
12 weeks of tape application perpendicular to sutured torso 
wounds on overall aesthetic appearance and width of the 
scars, as well as patient scar satisfaction at six months fol-
lowing surgery.
Materials and methods
This was a randomized controlled assessor blinded trial 
involving patients having elliptical skin excisions on the torso 
in a primary health care setting. The study was approved by 
the University of Queensland ethics committee (approval 
number #2008000535 April 2008). All patients gave written 
informed consent.
Setting & participants
Consecutive eligible patients were recruited by two gen-
eral practitioners (including the prin cipal researcher, HR), 
at a primary health skin cancer clinic in Townsville, North 
Queensland, Australia from June 2008 to January 2010.
Baseline demographic data, relevant medical history, 
degree of torso movement anticipated during the study 
period and lesion histology were documented (Table 1). 
Excision sites were recorded on body maps. The principal 
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 TABLE 1. Baseline characteristics of participants by treatment group
Characteristic
Control Group 
n=103
Intervention group 
n=92
P 
Age in years—mean (SD) 52.6 (15.4%) 51.4 (15.1%) 0.59
Women 50 (48.5%) 56 (60.9%) 0.10
Body mass index (kg/m2) – mean (SD) 27.0 (4.1%) 26.7 (4.5%) 0.61
Diagnoses of diabetes 8 (7.8%) 7 (7.6%) 0.97
Prescribed aspirin, clopidogrel and/or inhaled 
steroids
16 (15.5%) 9 (9.8%) 0.23
Smoking status 0.28
Ex-smoker 33 (32.0%) 27 (29.3%)
Current smoker 9 (8.7%) 15 (16.3%)
Level of activity at work 0.28
Not working 43 (41.7%) 32 (34.8%)
Sedentary occupation 39 (37.9%) 30 (32.6%)
Moderate bending/ lifting 12 (11.7%) 16 (17.4%)
Strenuous bending/ lifting 9 (8.7%) 14 (15.2%)
Histology of skin lesion 0.12
Basal cell carcinoma 42 (40.8%) 44 (47.8%)
Sqamous cell carcinoma 5 (4.9%) 9 (9.8%)
Cutaneous melanoma 11 (11.3%) 6 (6.5%)
Dysplastic naevus 34 (32.0%) 27 (29.3%)
Other naevus 3 (3.0%) 5 (5.4%)
Other lesion 8 (7.8%) 1 (1.1%)
Torso site 0.27
Upper back (above waist) 67 (65.0%) 59 (64.2%)
Lower back/buttock 10 (9.7%) 11 (11.9%)
Chest 22 (21.4%) 21 (22.8%)
Abdomen 4 (3.9%) 1 (1.1%)
Median post-excision length of scar before sutur-
ing [mm] (IQR)
33 (25, 37) 33 (28, 37.5) 0.41
Median post-excision width of scar before sutur-
ing [mm] (IQR) 
19 (15, 22) 19 (15, 22.5) 0.72
IQR= inter-quartile range; SD = standard deviation             
Moderate bending/ lifting<15kg (e.g. bowls/ gardening); 
Strenuous bending/ lifting >15kg (e.g. rowing/ weight training)
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Randomization and 
blinding
The allocation sequence was 
generated using a computer-
ized randomization schedule 
at the Discipline of General 
Practice at The University of 
Queensland. Randomization 
was done in blocks of six to 
ensure roughly equal numbers 
in each study group. Sequen-
tially numbered opaque sealed 
envelopes containing details 
of group allocation were only 
opened following wound clo-
sure to ensure blinding to ran-
domization during the surgical 
procedure. Participants were 
asked not to reveal their group allocation to the blinded 
outcome assessor. Scars were assessed 10 to 14 days after 
completion of the 12-week intervention so that there was no 
residual tape adhesive that might inadvertently reveal group 
allocation. Outcome data entry was done at the University 
of Queensland by a research assistant not directly involved 
in the trial.
Clinical outcomes
Maximal scar width was recorded to the nearest millimeter. 
Overall scar appearance and participant satisfaction with their 
scar were both appraised using five-point categorical scales.
Outcome assessment was undertaken by an independent 
blinded research nurse three and six months postoperatively. 
Overall scar appearance was evaluated and documented 
along with presence of scar elevation, depression and dys-
chromia. Reference photographs taken and categorized by 
the principal investigator (HR) before commencement of the 
trial helped ensure consistency of this assessment.
Participants completed adapted questionnaires [16] at the 
assessment visits. Participant satisfaction with the scar was 
ascertained as well as how perceived cosmetic results com-
pared to their expectation and whether they would use tapes 
for future torso scars if our study results proved favorable.
Sample size
It was hypothesized that a minimum mean difference of 2 
mm in wound width between taped participants and con-
trols would be clinically significant. To show this with statis-
tical confidence (power in excess of 80%; significance level 
0.05), 29 participants were required in each study group.
For overall scar appearance and patient scar satisfaction 
(both measured on categorical scales), it was hypothesized 
that a difference of at least one category between the two 
Figure 1. Standardized surgical procedure. [Copyright: ©2013 Rosengren et al.]
Figure 2. Randomization protocol. [Copyright: ©2013 Rosengren 
et al.]
Figure 3. Taped torso wound—a descriptive photo. [Copyright: 
©2013 Rosengren et al.]
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ments (p=0.343). Analgesics used were paracetamol (38), 
paracetamol with 30 mg codeine phosphate (4) and ibupro-
fen (2), but 77.4% (151) patients required no pain relief.
One participant developed allergy to the adhesive tapes 
and subsequently stopped taping. Surgical complications (1 
hematoma, 2 infection, 1 dehiscence, 2 stitch abscesses) were 
as infrequent in both study groups (p=0.804).
Characteristics of non-participants
Forty-five patients declined participation, mainly due to a 
lack of interest (73.3%). Participants were more likely to be 
female (p=0.005), less likely to take anticoagulants or inhaled 
steroids (p=0.049) and reported more exercise in their leisure 
time (p=0.042) than non-participants. Those who enrolled 
in but did not complete the study (41) were more likely to 
be younger (p<0.001), female (p=0.01) and more physically 
active at work (p=0.036).
Main outcome measures
The overall scar rating given by the blinded assessor at six 
months was significantly better in the intervention group 
(p=0.004) (Table 2) both for males (p=0.045) and females 
(p=0.045). Wounds were rated as good or very good in 
64.4% of taped participants and 38.4% controls, whereas 
they were rated as poor or very poor in 14.6% taped partici-
pants and 39.8% controls. Median scar width at six months 
was 1 mm less in taped participants than controls (p=0.015). 
When stratified by gender, there was no significant difference 
in scar width for females (p=0.155), but for men there was a 
study groups would be clinically significant. To show this with 
statistical confidence (power in excess of 80%; significance 
level 0.05), 78 participants were required in each study group.
For all outcomes to be assessed and allowing for a 25% 
drop out rate, we planned to enroll 204 patients.
Statistical analysis
Participant data were analyzed according to allocated study 
group, irrespective of protocol violation or non-compliance. 
Success of randomization was ascertained by comparing 
baseline information between groups. This included age, 
gender, diabetes, smoking history, degree of torso movement 
at work and in leisure time, body mass index, histology of 
lesion, torso site and wound dimensions.
Numerical data were described using mean values and 
standard deviations when approximately normally distrib-
uted or median values and inter-quartile ranges when skewed. 
Chi-square tests, t-tests and non-parametric Wilcoxon tests 
were used for baseline comparisons between participants 
and non-participants and between the study groups. Wound 
assessments and patient satisfaction scores were compared 
using non-parametric Wilcoxon tests.
Statistical analysis was conducted using SPSS version 18 
(PASW; SPSS Inc., Chicago, Illinois). P-values of less than 
0.05 were considered statistically significant.
Results
Baseline description of patients and skin lesions
Of 240 eligible patients, 195 opted to participate. Excisions 
were for skin cancer (44.1% BCCs, 7.2% SCCs) or suspi-
cious pigmented lesions (48.7%) (Table 1).
Those with lesions requiring a second wider excision (16 
melanoma; two incompletely excised BCCs) were excluded 
from the study, leaving 177 participants (86 intervention; 91 
control). One in-situ melanoma with adequate margins on 
primary excision remained in the study. Forty-one partici-
pants withdrew or were lost to follow-up, leaving 63 (73.3% 
of 86) in the intervention and 73 (80.2% of 91) in the con-
trol group at six months (Figure 4).
At baseline there were no significant differences between 
study groups (Table 1) with the mean age being 52 years (SD 
15.2, range 18 to 80 years) and 53.3% (104) being female. 
Other than gender there were no differences between the 
study groups at six months, with 38.4% (28) of controls 
and 58.7% (37) of intervention participants being female 
(p=0.013).
Treatment and complications
There was no difference between study groups in the num-
ber of deep sutures used (p=0.93; median number three; 
range from two to ten) or postoperative pain relief require-
Figure 4. Randomization flow chart for participants. [Copyright: 
©2013 Rosengren et al.]
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Discussion
Twelve weeks of taping torso scars postoperatively sig-
nificantly improved independent assessment of overall scar 
appearance at six months. There was no significant dif-
ference in the number of participants with at least some 
scar depression, elevation or dyschromia in the two study 
groups. Since degree of these three variables was not evalu-
ated, however, these observations may have little clinical 
relevance.
Taping reduced median scar width by a modest 1 mm, 
which, though statistically significant, was thought not to 
be clinically relevant. When stratified by gender, however, 
the observed 3 mm reduction in scar width in taped males 
may be of clinical as well as statistical significance. In non-
taped controls, scars were significantly wider in males than 
females, possibly because men subject the torso to more ten-
sion and stretch. This could explain why taping, which may 
help support the healing wound, had a greater impact on 
scar width in males.
Participant satisfaction was high in our study and not 
further improved by taping. A major limitation of this study, 
however, is that we did not have adequate power to show 
with statistical confidence whether taping affected patient 
satisfaction levels. Due to time restrictions and a higher than 
predicted dropout rate, only 136, rather than the required 
156 participants, attended for six-month assessment. Fur-
thermore there may have been under-reporting of dissatisfac-
3.0 mm difference in median width between the control (5.0 
mm, IQR = 2.0, 10.0) and intervention groups (2.0 mm, IQR 
= 1.0, 5.5) (p=0.036) (Table 2). There was no significant dif-
ference between study groups in the number of participants 
with at least some scar depression, elevation or dyschromia.
The intervention was well tolerated with just one of 85 
participants initially randomized to the intervention devel-
oping an allergy to the tapes. No other problems arose as a 
result of taping.
Subjective scar assessment at six months was the same 
in both study groups (p=0.649) even when stratified by gen-
der (Table 3). Only one participant (control) reported the 
cosmetic outcome to be worse than expected; 98.6% (71) 
controls and 93.2% (55) of the intervention group would 
have opted to have the surgery done again (p=0.174) (Table 
2). The majority of participants (82.4% intervention group; 
69.9% controls; p=0.148) even when stratified by gender 
(70.4% males; 81.5% females; p=0.221) indicated they 
would use tapes for a future scar if our results proved favor-
able (Table 3).
Though trends suggested that median scar width and 
overall scar appearance was better in the intervention group 
three months postoperatively, this did not reach statistical sig-
nificance. Median scar width was 1 mm less in taped partici-
pants (3.0 mm, IQR = 2.0, 5.0) than controls (4.0 mm, IQR = 
2.5,6.0) (p=0.064), while overall scar appearance rated good/
very good in 53% taped participants compared to 43% con-
trols (p=0.259) at three months following surgery.
 TABLE 2. Independent blinded scar assessment at six months
Control 
N=73
Taped 
N=63
p-value
Overall rating of scar appearance  0.004
        Very good 11 (15.1%) 10 (16.1%)
        Good 17 (23.3%) 29 (46.8%)
        Okay 16 (21.9%) 13 (21.0%)
        Poor 25 (34.2%) 10 (16.1%)
        Very poor 4 (5.5%) 0
Median width of scar (IQR) [mm] 4.0 (2.0, 7.5) 3.0 (2.0, 5.0) 0.015
Median length of scar (IQR) [mm] 36.0 (29.0,42.5) 35.0 (28.0,41.0) 0.39
Scar elevation 8 (11.0%) 4 (6.5%) 0.55
Scar depression 26 (35.6%) 22 (35. 5%) 0.99
Discolouring 69 (94.5%) 57 (91.9%) 0.73
IQR- interquartile range
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Similar to other studies [17,18], we found that the inde-
pendent assessor was less satisfied with the scar than the 
participants themselves. Participant satisfaction with torso 
scars was much higher in our study than in other studies, 
however [7-9]. Reasons for this may include altered partici-
pant expectation and employment of a different suture tech-
nique in our study. On recruitment we informed participants 
that the study was being conducted because torso scars tend 
to look worse than scars elsewhere. Preoperative expecta-
tions are known to be an important determinant of patient 
satisfaction [8]. Only one participant reported a worse than 
expected outcome at six months.
Though there has not been sufficient research on the 
use of absorbable sutures [19], there is evidence that their 
tion, as many participants were well known to their primary 
health care surgeon and may have wished not to offend. 
Additionally, almost two-thirds of the excisions were on the 
upper back, resulting in scars that would have been difficult 
for some participants to clearly visualize possibly leading to 
inappropriately high satisfaction scores.
Blinding the doctor to group allocation before wound 
closure helped ensure a uniform surgical technique for 
all participants. Fortnightly phone calls may have helped 
improve compliance in taped participants. Bias in reported 
satisfaction was prevented by contacting controls with equal 
regularity. Bias in scar assessment was eliminated by blind-
ing the independent assessor, who used a visual aid to help 
categorize scars and improve uniformity in scar rating.
 TABLE 3. Participant questionnaire outcome measures at 6 month follow-up  
Control 
 (n=73)
Taped 
(n=63)
p-value
How satisfied are you with how your 
scar looks?
0.65
 Very satisfied 33 (45.8%) 25 (43.1%)
 Satisfied 26 (36.1%) 21 (36.2%)
 Neutral 13 (18.1%) 11 (19%)
 Dissatisfied 0 1 (1.7%)
 Very dissatisfied 0 0
How does the scar compare with what 
you expected?
4.0 (2.0, 7.5) 3.0 (2.0, 5.0) 0.015
 My scar is invisible to me 23 (31.9%) 18 (31.6%)
 My scar is better than I expected 28 (38.9%) 16 (28.1%)
 My scar is about what I expected 20 (27.8%) 23 (40.4%)
 My scar is worse than I expected 1 (1.4%) 0
Given the scarring result would you 
make the same decision to have surgery?
0.17
 Yes 71 (98.6%) 55 (93.2%)
If we find that taping does make a dif-
ference to the scar would you tape a 
future torso scar after surgery?
0.15
 Yes 51 (69.9%) 52 (82.4%)
 No   4 (5.5%)   3 (4.8%)
 Don’t know 16 (21.9%)   6 (9.6%)
 Not answered   2 (2.7%)   2 (3.2%)
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Conclusion
This study has shown that 12 weeks taping of sutured torso 
scars is a safe, effective and well-tolerated intervention that 
may significantly improve scar appearance at six months.
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